Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Chinese Health Care Reform: Market Opportunities And Challenges

This article was originally published in The Gray Sheet

Executive Summary

China's renewed emphasis on reforming its health care system is creating both opportunities and challenges for foreign manufacturers doing business there, according to speakers at AdvaMed's 2008 MedTech Conference in Washington, D.C

You may also be interested in...



Despite Reg Challenges, China Market Access Gradually Improving

China's regulatory environment remains a struggle for device firms seeking to gain marketing or manufacturing footholds in the country, but meaningful government efforts to improve the business climate are making a dent, suggest device executives who are focused on the region

Despite Reg Challenges, China Market Access Gradually Improving

China’s regulatory environment remains a struggle for device firms seeking to gain marketing or manufacturing footholds in the country, but meaningful government efforts to improve the business climate are making a dent, suggest device executives who are focused on the region.

Despite Reg Challenges, China Market Access Gradually Improving

China’s regulatory environment remains a struggle for device firms seeking to gain marketing or manufacturing footholds in the country, but meaningful government efforts to improve the business climate are making a dent, suggest device executives who are focused on the region.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT026637

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel